Baqsimi® (glukagon näspulver): Passiv absorption

Detailed information

The Nasal Glucagon powder is absorbed passively through the nasal mucosa, and delivery does not require the person to be conscious or to inhale.^1-3

Nasal Glucagon is a 3 mg glucagon dry nasal powder. It is delivered via a nasal dosing device that

• is ready-to-use and requires no reconstitution

• is a compact, portable, single-use, drug-device combination, and 

• does not require a person to inhale.^1,2

References

1. Rickels MR, Ruedy KJ, Foster NC, et al; T1D Exchange Intranasal Glucagon Investigators. Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: a randomized crossover noninferiority study. Diabetes Care. 2016;39(2):264-270. https://doi.org/10.2337/dc15-1498

2. Sherr JL, Ruedy KJ, Foster NC, et al; T1D Exchange Intranasal Glucagon Investigators. Glucagon nasal powder: a promising alternative to intramuscular glucagon in youth with type 1 diabetes. Diabetes Care. 2016;39(4):555-562. https://doi.org/10.2337/dc15-1606

3. Baqsimi [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

Glossary

NG = nasal glucagon (glucagon nasal powder)